Revisiting public health programming in Nigeria: challenges and solutions

por Oleribe, Obinna Ositadimma, Nwanyanwu, Okey, Shen, Eric Yi-Liang, Taylor-Robinson, Simon D
Publicado 2019

Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways

por Mandras, Stacy, Kovacs, Gabor, Olschewski, Horst, Broderick, Meredith, Nelsen, Andrew, Shen, Eric, Champion, Hunter
Publicado 2021

Novel dose–response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations

por Ramani, Gautam, Cassady, Steven, Shen, Eric, Broderick, Meredith, Wasik, Allie, Sui, Qun, Nelsen, Andrew
Publicado 2020

The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery

por Shen, Eric Yi-Liang, U, Mei Ran Abellona, Cox, I. Jane, Taylor-Robinson, Simon D.
Publicado 2023

The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension

por Wronski, Samantha L., Mordin, Margaret, Kelley, Kim, Anguiano, Rebekah H., Classi, Peter, Shen, Eric, Manaker, Scott
Publicado 2019

Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily

por Shapiro, Shelley, Mandras, Stacy, Restrepo-Jaramillo, Ricardo, Shen, Eric, Broderick, Meredith, Rao, Youlan, Lee, Dasom, Nelsen, Andrew C.
Publicado 2021

A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial

por Nathan, Steven D., Medarov, Boris, Ho, Lawrence, Kingrey, John, Hong, Taekwon, Rao, Youlan, Shen, Eric, Smith, Peter, Deng, Chunqin, Waxman, Aaron
Publicado 2023

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial

por Nathan, Steven D., Tapson, Victor F., Elwing, Jean, Rischard, Franz, Mehta, Jinesh, Shapiro, Shelley, Shen, Eric, Deng, Chunqin, Smith, Peter, Waxman, Aaron
Publicado 2021

Draft genome of the most devastating insect pest of coffee worldwide: the coffee berry borer, Hypothenemus hampei

por Vega, Fernando E., Brown, Stuart M., Chen, Hao, Shen, Eric, Nair, Mridul B., Ceja-Navarro, Javier A., Brodie, Eoin L., Infante, Francisco, Dowd, Patrick F., Pain, Arnab
Publicado 2015

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

por Waxman, Aaron, Restrepo-Jaramillo, Ricardo, Thenappan, Thenappan, Engel, Peter, Bajwa, Abubakr, Ravichandran, Ashwin, Feldman, Jeremy, Hajari Case, Amy, Argula, Rahul G., Tapson, Victor, Smith, Peter, Deng, Chunqin, Shen, Eric, Nathan, Steven D.
Publicado 2023

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development ini...

por Nikkho, Sylvia M., Richter, Manuel J., Shen, Eric, Abman, Steven H., Antoniou, Katerina, Chung, Jonathan, Fernandes, Peter, Hassoun, Paul, Lazarus, Howard M., Olschewski, Horst, Piccari, Lucilla, Psotka, Mitchell, Saggar, Rajan, Shlobin, Oksana A., Stockbridge, Norman, Vitulo, Patrizio, Vizza, Carmine Dario, Wort, Stephen J., Nathan, Steven D.
Publicado 2022